Diagnostics Archives

More News! 18 Jul 2022

Purespring Therapeutics and SwanBio Therapeutics announce agreement for use of FunSel screening platform

A licensing agreement for use of the FunSel screening platform has been announced by Purespring Therapeutics and SwanBio. Under the terms of the agreement, SwanBio will license the FunSel screening platform from Purespring to explore new targets for early-stage pipeline programs. SwanBio will have the option to develop any targets identified and to own and […]

July 18, 2022 - 2 minutesmins - By Liza Laws

News and Trends 8 Jul 2022

World’s first research project for an early detection, multi-cancer screening test launched in Singapore

A project for the discovery and validation of new combinations of biomarkers that can detect multi-cancer early has been launched in Singapore. Biotechnology company, MiRXES Ptr Ltd, announced this week the signing of a memorandum of understanding signaling the launch of Project CADENCE (Cancer Detected Early caN be CurEd). It is the world’s first large-scale […]

July 8, 2022 - 4 minutesmins - By Liza Laws

In Depth 19 Jan 2022

Glycans Hit the Sweet Spot in Diagnostics

The surface of our cells are covered in sugar molecules called glycans. The field of glycomics leverages their enormous diversity to develop better and more precise diagnostics. More commonly known as sugars or carbohydrates, glycans are involved in a range of crucial biological roles, including maintaining tissue elasticity, tackling pathogens, and modulating the immune system. […]

January 19, 2022 - 5 minutesmins - By Sachin Rawat

News and Trends 24 Sep 2021

Breath Testing To Be Tapped by UK Pioneer with €50M Fundraising

After years of under-fulfilled promise, breath tests for cancer, liver disease, and respiratory conditions appear to be taking off with UK biotech Owlstone Medical raking in almost €50M (£42M) in an oversubscribed Series D funding round. The round, whose original target was about €43M, was led by the Hong Kong-based Horizons Ventures and was joined […]

September 24, 2021 - 3 minutesmins - By Victor Kotsev

News and Trends 30 Jul 2021

British Diagnostics Biotech Becomes Social Enterprise After Acquisition

UK rapid diagnostics company Mologic will convert into a social enterprise after being acquired by a group of philanthropic funds and investors, in what experts predict may become an increasingly popular trend. The British biotech Mologic will entirely reinvest any profits into widening global access to affordable medical technology after being acquired in a deal […]

July 30, 2021 - 4 minutesmins - By Anita Chakraverty

In Depth 28 Jul 2021

Tracking Covid-19 Cases with Wastewater Testing

Researchers have been using DNA testing technology to detect traces of the SARS-CoV-2 virus behind Covid-19 in wastewater streams in order to predict and prevent outbreaks locally. Wastewater testing can be a useful method to study the behavior of people living in a specific region. For example, a European study conducted back in 2014 looked […]

July 28, 2021 - 5 minutesmins - By Sachin Rawat

Best in Biotech 30 Jun 2021

Scotland’s Top 10 Biotech Companies to Watch Out For

Scotland has a thriving life sciences ecosystem with strengths in oncology, genetic engineering, and industrial biotech. Let’s pick up the bagpipes as we tour the top 10 biotech companies in Scotland. Scotland is the UK’s second-most populous country, boasting picturesque scenery, a rich history, and a strong focus on sustainability. There is a diverse range […]

June 30, 2021 - 11 minutesmins - By Jonathan Smith

spatial transcriptomics 10x genomics readcoor

In Depth 12 May 2021

Spatial Transcriptomics: A Window into Disease

The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease? DNA and RNA sequencing technology has undergone a revolution in the last decade, with companies working to provide ever cheaper and faster ways to explore our genetics. This stride […]

May 12, 2021 - 8 minutesmins - By Jonathan Smith

News and Trends 20 Apr 2021

Pandemic Boosts Diagnostics Field with High Revenues and Acquisitions

The US medtech firm Hologic has bought the Finnish-French biotech Mobidiag for around €668M in the latest of a series of mergers, acquisitions, and stock market launches taking over the diagnostics market. Hologic’s move is the latest in a flurry of activity from the women’s health specialist, which has snapped up Diagenode in Belgium, Biotheranostics […]

April 20, 2021 - 5 minutesmins - By Anita Chakraverty

News and Trends 18 Mar 2021

Europe Falls Behind in Efforts to Track Covid-19 Variants

As barely a third of European countries meet targets to track concerning Covid-19 variants, diagnostics and genomics companies are scrambling to help them tackle this challenge. New strains of the Covid-19 coronavirus are sweeping Europe as vaccine distribution efforts roll on. These variants often gain traction when mutations let them become more virulent or spread […]

March 18, 2021 - 5 minutesmins - By Anita Chakraverty

News and Trends 25 Feb 2021

Legal Fights Accompany Big Fundraises in Liquid Biopsy Scene

A recent patent fight between the liquid biopsy companies Natera and Inivata is only the latest of many spats over DNA sequencing technology that could potentially revolutionize the detection and treatment of cancer. Earlier this month, the UK-US biotech Inivata raised €29M in the second closing of a Series C round. The company will use […]

February 25, 2021 - 5 minutesmins - By Anita Chakraverty

Interview 1 Feb 2021

Democratized DNA Synthesis: A Game-Changer Against Covid-19

DNA synthesis is one of the pillars of Covid-19 research that has suffered supply disruptions during lockdowns. Thomas Ybert, CEO of DNA Script, discusses the French company’s plans to protect research from future disruptions by giving every lab the ability to synthesize its own DNA molecules. The Covid-19 pandemic has highlighted more than ever the […]

February 1, 2021 - 6 minutesmins - By Jonathan Smith

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us